Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-74.87	-215.84	859.05
Graham Fair Price	16.07	7.51	6.47
PEG	-27.21	0.27	-0.37
Price/Book	-27.62	0.60	0.82
Price/Cash Flow	127.30	43.63	-19.19
Prices/Earnings	-46.00	10.40	19.26
Price/Sales	-28.42	4.53	6.33
Price/FCF	127.30	43.63	-19.19
Naive Interpretation	member

01 - Valuation · Somewhat Positive

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	0.26	1.00	1.00
Operating Margin	-10.16	0.18	0.20
ROA	34.68	< 0.005	< 0.005
ROE	0.01	0.01	34.04
ROIC	0.01	0.01	-16.29
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.02	0.29	-92.08
Dividends QOQ	-0.03	0.06	117.53
EBIT QOQ	-0.12	-0.09	23.80
EPS QOQ	-0.52	0.38	-25.82
FCF QOQ	-1.82	1.32	-27.34
Revenue QOQ	0.88	0.02	-98.29
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	25541.22	100.00
Days Sales Outstanding (DSO)	25.37	25.85	1.89
Inventory Turnover	0.00	< 0.005	100.00
Debt/Capitalization	0.33	0.34	0.68
Quick Ratio	0.09	0.11	15.97
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	13.20	13.23	0.25
Cash	1.81	1.90	4.66
Capex	< 0.005	< 0.005	18.79
Free Cash Flow	-0.57	0.18	-68.08
Revenue	1.72	1.74	1.37
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	0.09	0.10	16.61
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	290.42	-89.74	-69.10
Naive Interpretation	Member

06 - Financial Health · Bad

Rating